Novel therapy of focal glomerulosclerosis with mycophenolate and angiotensin blockade

Pediatric Nephrology

Volumn 18, Issue 8, 2003, Pages 772-777

  Montané, Brenda ^a   Abitbol, Carolyn ^a   Chandar, Jayanthi ^a   Strauss, José ^a   Zilleruelo, Gastón ^a  

^a UNIVERSITY OF MIAMI   (United States)

Author keywords

Angiotensin blockade; Focal glomerulosclerosis; Mycophenolate; Nephrotic syndrome

Indexed keywords

ALKYLATING AGENT; ANGIOTENSIN ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; CANDESARTAN; CAPTOPRIL; CHLORAMBUCIL; CHOLESTEROL; CORTICOSTEROID; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LOSARTAN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; PROTEIN; RAPAMYCIN; STEROID; TACROLIMUS; TRIACYLGLYCEROL;

ADOLESCENT; ANEMIA; ARTICLE; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CREATININE URINE LEVEL; DRUG MECHANISM; FEMALE; FOCAL GLOMERULOSCLEROSIS; GASTROINTESTINAL SYMPTOM; GLUCOSE INTOLERANCE; HUMAN; HYPERLIPIDEMIA; LEUKOPENIA; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MALE; NEPHROTOXICITY; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; TERATOGENICITY; THROMBOCYTOPENIA; TREATMENT FAILURE; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; GLUCOCORTICOIDS; HUMANS; MALE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; NEPHROTIC SYNDROME; PILOT PROJECTS; PREDNISONE; RECEPTORS, ANGIOTENSIN;

EID: 0042632513     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-003-1174-5     Document Type: Article

References (38)

1. International Study of Kidney Disease in Children (1981) The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. J Pediatr 98:561-564
2. Cattran DC, Rao P (1998) Long-term outcome in children and adults with classic focal segmental glomerulosclerosis. Am J Kidney Dis 32:72-79
3. Martinelli R, Okumura AS, Pereira LJ, Rocha H (2001) Primary focal segmental glomerulosclerosis in children: prognostic factors. Pediatr Nephrol 16:658-661
4. Cameron JS, Turner DR, Ogg CS, Chantler C, Williams DG (1978) The long-term prognosis of patients with focal segmental glomerulosclerosis. Clin Nephrol 10:213-218
5. Ichikawa I, Fogo A (1996) Focal segmental glomerulosclerosis. Pediatr Nephrol 10:374-391
6. Aviles DH, Irwin KC, Dublin LS, Vehaskari VM (1999) Aggressive treatment of severe idiopathic focal segmental glomerulosclerosis. Pediatr Nephrol 13:298-300
7. Burgess E (1999) Management of focal segmental glomerulosclerosis: evidence-based recommendations. Kidney Int [Suppl] 70:S26-S32
8. Tune BM, Lieberman E, Mendoza SM (1996) Steroid-resistant nephrotic focal segmental glomerulosclerosis: a treatable disease. Pediatr Nephrol 10:772-778
9. Maschio G, Alberti D, Janin G, Locatelli F, Mann JF, Motolese M, Ponticelli C, Ritz E, Zucchelli P (1996) Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med 334:939-945
10. Briggs WA, Choi MJ, Scheel PJ (1998) Successful mycophenolate mofetil treatment of glomerular disease. Am J Kidney Dis 31:213-217
11. Corna D, Morigi M, Facchinetti D, Bertani T, Zoja C, Remuzzi G (1997) Mycophenolate mofetil limits renal damage and prolongs life in murine lupus autoimmune disease. Kidney Int. 51:1583-1589
12. Fujihara CK, De LN, Malheiros I, Antunes GR, Oliveira IB de, Zatz R (2000) Combined mycophenolate mofetil and losartan therapy arrests established injury in the remnant kidney. J Am Soc Nephrol 11:283-290
13. Abitbol CL, Zilleruelo G, Freundlich M, Strauss J (1990) Quantitation of proteinuria with urinary protein/creatinine ratios and random testing with dipsticks in nephrotic children. J Pediatr 116:243-247
14. Hogg RJ, Portman R, Milliner D, Lemley K, Eddy A, Ingelfinger J (2000) Evaluation and management of proteinuria and nephrotic syndrome in children: recommendations from a pediatric nephrology panel established at the National Kidney Foundation conference on proteinuria, albuminuria, risk, assessment, detection, and elimination (PARADE). Pediatrics 105:1242-1249
15. Laverman GD, Navis G, Henning RH, Jong PE de, Zeeuw (2002) Dual renin-angiotensin system blockade at optimal doses for proteinuria. Kidney Int 62:1020-1025
16. Woolf AS (1997) Multiple causes of human kidney malformations. Arch Dis Child 77:471-474
17. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents (1996) Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. Pediatrics 98:649-658
18. National Center for Health Statistics. Centers for Disease Control (1978) NCHS growth curves for children: birth-18 years. Series 11, 165. DHEW publication (PHS) 78:1650. U.S. Government Printing Office, Washington, DC
19. Hammer LD, Kraemer H, Wilson DM, Ritter PL, Dornbusch SM (1991) Standardized percentile curves of body mass index for children and adolescents. Am J Dis Child 145:259-263
20. Schwartz G, Brion LP, Spitzer A (1987) The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 34:571-590
21. Motulsky H (1995) Intuitive biostatistics, 2nd edn. Oxford University Press, New York, pp 207-262
22. Srivastava T, Simon SD, Alon US (1999) High incidence of focal segmental glomerulosclerosis in nephrotic syndrome of childhood. Pediatr Nephrol 13:13-18
23. Waldo FB, Benfield MR, Kohaut EC (1998) Therapy of focal and segmental glomerulosclerosis with methylprednisolone, cyclosporine A, and prednisone. Pediatr Nephrol 12:397-400
24. Tune BM, Kirpekar R, Sibley RK, Reznik VM, Griswold WR, Mendoza SA (1995) Intravenous methylprednisolone and oral alkylating agent therapy of prednisone-resistant pediatric focal segmental glomerulosclerosis: a long-term follow-up. Clin Nephrol 43:84-88
25. Matsumoto KM, Ito Y, Abe (1990) Effect of methylprednisolone pulse therapy on cellular immunity abnormalities in a patient with lipoid nephrosis. Nephron 56:339-340
26. Wollheim FA (1984) Acute and long-term complications of corticosteroid pulse therapy. Scand J Rheumatol [Suppl] 54:27-32
27. Ingulli E, Singh A, Baqi N, Ahmad H, Moazami S, Tejani A (1995) Aggressive, long-term cyclosporine therapy for steroid-resistant focal segmental glomerulosclerosis. J Am Soc Nephrol 5:1820-1825
28. Melocoton TL, Kamil ES, Cohen AH, Fine RA (1991) Longterm cyclosporine A treatment of steroid-resistant and steroid-dependent nephrotic syndrome. Am J Kidney Dis 18:583-588
29. Gregory MJ, Smoyer WE, Sedman E, Kershaw DB, Valentini RP, Johnson K, Bunchman TE (1996) Long-term cyclosporine therapy for pediatric nephrotic syndrome: a clinical and histologic analysis. J Am Soc Nephrol 7:543-549
30. Cattran DC, Appel GB, Hebert LA, Hunsicker LG, Pohl MA, Hoy WE, Maxwell DR, Kunis CL (1999) A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group. Kidney Int 56:2220-2226
31. Borel JF, Feurer C, Gubler HU, Stahelin H (1976) Biological effects of cyclosporin A: a new antilymphocytic agent. Agents Actions 6:468-475
32. Silva JMP, Oliveira EA, Marino VS, Oliveira JS, Torres RM, Ribeiro ALP, Simal CJ, Ribeiro MC (2002) Premature acute myocardial infarction in a child with nephrotic syndrome. Pediatr Nephrol 17:169-172
33. Taal MW, Brenner BM (2000) Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists. Kidney Int 57:1803-1817
34. Mimran A, Ribstein J (1999) Angiotensin receptor blockers: pharmacology and clinical significance. J Am Soc Nephrol 10 [Suppl 12]: S273-S277
35. Hori C, Hiraoka M, Yoshikawa N, Tsuzuki K, Yoshida Y, Yoshioka K, Fujisawa K, Tsukahara H, Ohshima Y, Mayumi M (2001) Significance of ACE genotypes and medical treatments in childhood focal glomerulosclerosis. Nephron 88:313-319
36. Palmer BF (2002) Renal dysfunction complicating the treatment of hypertension. N Engl J Med 347:1256-1261
37. Allison AC, Eugui EM (1993) Immunosuppressive and other effects of mycophenolic acid and an ester prodrug, mycophenolate mofetil. Immunol Rev 136:5-28
38. Lipsky JJ (1996) Mycophenolate mofetil. Lancet 348:1357-1359